Host microbiome interactions in chronic itch
Th2 mRNA gene expression analysis separates Prurigo nodularis into two immune signature groups
Safety and efficacy of barzolvolimab, an anti-KIT monoclonal antibody, in adults with moderate-to-severe prurigo nodularis: A randomized phase 1b intravenous single dose study
Nemolizumab Treatment Normalizes Dysregulated Microbiome in Lesional Prurigo Nodularis
Accessibility Tools
